Meeting
2017 ASCO Annual Meeting
Polypharmacy and potentially inappropriate medication use in older patients with aggressive non-Hodgkin lymphoma (NHL) leads to inferior survival and increased treatment-related toxicities.
Authors
Richard Jirui Lin
NYU Langone Medical Center, New York, NY
Richard Jirui Lin , Helen Ma , Robin Guo , Michael L. Grossbard , Andrea B. Troxel , Catherine S. Magid Diefenbach
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Patient and Survivor Care
Track
Patient and Survivor Care
Sub Track
Geriatric Oncology
Citation
J Clin Oncol 35, 2017 (suppl; abstr 10039)
DOI
10.1200/JCO.2017.35.15_suppl.10039
Abstract #
10039
Poster Bd #
28
Abstract Disclosures
Similar Posters
Poster
2016 Palliative and Supportive Care in Oncology Symposium
Contribution of polypharmacy and potentially inappropriate medication use to inferior survival in older patients with aggressive lymphoma.
First Author: Richard Jirui Lin
Poster
2021 ASCO Annual Meeting
Survival outcomes, treatment toxicity, and healthcare utilization in older adults with aggressive non-Hodgkin lymphoma (NHL).
First Author: Mitchell W. Lavoie
Poster
2016 ASCO Annual Meeting
Adverse impact of polypharmacy and potentially inappropriate medication use in newly diagnosed, elderly lymphoma patients.
First Author: Richard Jirui Lin
Poster
2024 ASCO Genitourinary Cancers Symposium
Real-world efficacy and toxicity of ipilimumab and nivolumab as first line treatment of metastatic renal cell carcinoma (mRCC) in a subpopulation of elderly and poor performance status patients.
First Author: Ana-Alicia Beltran-Bless